Cambrex Corp (NYSE:CBM)
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
EPS Ranking 76
Recs
A solid player among the small caps in this industry. Look for stock price increase as US corporare tax structure is stabilized over the next few years.
Recs
Caps Most up
Category Personal Score
Growth Rates % Very Low
Price Ratios High
Profit Margins % High
Financial Condition High
Investment Returns % High
Management Efficiency High
Total Score Very Low
Recs
$14/share dividend on May 4
Recs
Reading EPS100Momentum's blog led me to CBM and the news of the company's intent to distribute a large dividend of $13.50 - $14.50 at an unspecified date in the future.
After watching SMG on the news of it's special one-time $8 dividend, there can be little doubt that CBM will appreciate considerably as the record date for the dividend approachs.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 6 of 6